BRIEF-Cartesian Therapeutics Announces Positive Topline Results From Phase 2B Trial Of Descartes-08 In Patients With Myasthenia Gravis

Reuters07-02

July 2 (Reuters) - Cartesian Therapeutics Inc :

* CARTESIAN THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 2B TRIAL OF DESCARTES-08 IN PATIENTS WITH MYASTHENIA GRAVIS

* CARTESIAN THERAPEUTICS INC - TRIAL MET PRIMARY ENDPOINT WITH STATISTICAL SIGNIFICANCE

* CARTESIAN THERAPEUTICS INC - SAFETY PROFILE CONTINUES TO SUPPORT OUTPATIENT ADMINISTRATION

* CARTESIAN THERAPEUTICS INC - COMPANY EXPECTS TO HOLD END-OF-PHASE 2 MEETING WITH FDA BY YEAR-END

* CARTESIAN THERAPEUTICS INC - ALSO ANNOUNCED POSITIVE UPDATED RESULTS FROM TWO PATIENTS ENROLLED IN PHASE 2A OPEN-LABEL PORTION OF TRIAL

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment